Jindal Stainless, Alembic Pharmaceuticals and Coromandel International to see some action today

Ceat Ltd. | Tyres & Allied | Automobiles | BSE: 500878 | NSE: CEATLTD

18 Jun 2024 Evaluate

Jindal Stainless has completed acquisition of remaining 46% equity stake in Chromeni Steels (CSPL). Consequently, CSPL has become a wholly-owned subsidiary of the Company with effect from June 15, 2024. As disclosed at the time of acquisition of 54% equity stake, this acquisition of CSPL would enable the Company to increase its cold rolled capacity in its product mix which will strengthen the Company’s presence in the value-added segment in the long term. Now, acquisition of remaining 46% equity stake will further help in better control, uniformity of policies and greater synergies between the two companies.

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Firazyr Injection, 30 mg/3 mL (10 mg/mL), of Takeda Pharmaceuticals U.S.A., Inc. Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

Coromandel International and The ICAR-National Bureau of Soil Survey & Land Use Planning (ICAR-NBSS&LUP) have signed a Memorandum of Understanding (MoU). This collaboration aims to enhance the dissemination of improved soil test-based crop nutrition management to benefit the farmers in Maharashtra, particularly in the Vidarbha and Marathwada regions. This partnership will focus on soil test-based datasets generated by NBSS&LUP and best nutritional management solutions provided by Coromandel for better soil health and to improve crop productivity of the region. This partnership further aims to foster better coordination, research exchange, and support for the farming community.

CEAT has planned to invest Rs 45.00 lakh in Cleanwin Energy Five LLP as per the proposed power delivery agreement to be signed and executed between the Company and Cleanwin Energy Five LLP. The Board of Directors of the Company at its meeting held on June 17, 2024, has approved the same.

Bondada Engineering has received work orders from M/s. Bharti Airtel. The company has received work orders for supply of 6 Mtr Height GI pole Wt 60kg (Hot Dipped Galvanised) without Base, amounting to Rs 2.05 crore (including GST) to Tamilnadu.

TARC has received approval for raising funds from Banks/ NBFCs and / or fresh issuance of Non-Convertible Debentures (NCDs) on Private placement basis not exceeding Rs 750 crore to refinance the existing NCDs of the company. The Board of Directors of the company in their meeting held on June 15, 2024 has accorded in-principal approval for the same.

Vishnu Prakash R Punglia has received Letter of Acceptance (LoA) from the Office of DY CE-C-BKN-ENGINEERING, North Western Railway Bikaner. The Letter of Acceptance pertains to the project titled ‘Earthwork in filling and cutting in formation, blanketing, trolley refuges, toe, wall, retaining wall, pitching, construction of Minor Bridges & LHS, FOB, Platform, Platform Shelters, S&T structures, cable duct and other ancillary works between Sadulpur to Churu in Connection with Churu- Sadulpur Doubling Project.’

CEAT Share Price

3713.55 12.90 (0.35%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
MRF	139772.66
Apollo Tyres	445.30
CEAT	3713.55
Balkrishna Inds.	2329.80
JK Tyres & Inds.	428.30
View more..

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Jindal Stainless, Alembic Pharmaceuticals and Coromandel International to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.